Polymorphonuclear leukocyte integrin pattern, at baseline and after activation, in type 2 diabetic subjects with macrovascular complications

Acta Diabetologica

Volumn 40, Issue 1, 2003, Pages 14-19

  Caimi, G ^a   Montana, M ^a   Ferrara, F ^b   Porretto, F ^b   Musso, M ^b   Canino, B ^a   Lo Presti, R ^a  

^a UNIVERSITY OF PALERMO   (Italy)

^b UNIVERSITY OF PALERMO   (Italy)

Author keywords

Atherosclerosis; Diabetes mellitus; Integrins; Polymorphonuclear leukocyte

Indexed keywords

CD11B ANTIGEN; CD18 ANTIGEN; GLYCOPROTEIN P 15095; INTEGRIN; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 1;

ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; ATHEROSCLEROSIS; CEREBROVASCULAR DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; DEPHOSPHORYLATION; DIABETIC ANGIOPATHY; FEMALE; FLOW CYTOMETRY; GENE CONTROL; HUMAN; IN VITRO STUDY; ISCHEMIC HEART DISEASE; LEUKOCYTE ACTIVATION; MALE; NEUTROPHIL; NON INSULIN DEPENDENT DIABETES MELLITUS; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; UPREGULATION;

AGED; ANTIGENS, CD11A; ANTIGENS, CD11B; ANTIGENS, CD11C; ANTIGENS, CD18; DIABETES MELLITUS, TYPE 2; DIABETIC ANGIOPATHIES; FEMALE; HUMANS; INTEGRINS; MALE; MIDDLE AGED; NEUTROPHILS; TETRADECANOYLPHORBOL ACETATE;

EID: 0037344971     PISSN: 09405429     EISSN: None     Source Type: Journal    
DOI: 10.1007/s005920300003     Document Type: Article

References (51)

1. Albelda SM, Buck CA (1990) Integrins and other cell adhesion molecules. FASEB J 4:2868-2880
2. Longhurst CM, Jennings LK (1998) Integrin-mediated signal transduction. Cell Mol Life Sci 54:514-526
3. Gahmberg CG, Valmu L, Fagerholm S, Kotovuori P, Ihanus E, Tian L, Pessa-Morikawa T (1998) Leukocyte integrins and inflammation. Cell Mol Life Sci 54:549-555
4. Bevilacqua MP, Nelson RM, Mannori G, Cecconi O (1994) Endothelial-leukocyte adhesion molecules in human disease. Annu Rev Med 45:361-378
5. Blann AD, McCollum CN (1994) Circulating endothelial cell/leukocyte adhesion molecules in atherosclerosis. Thromb Haemost 72:151-154
6. Tschoepe D (1996) Adhesion molecules influencing atherosclerosis. Diabetes Res Clin Pract 30[Suppl]:19-24
7. O'Brien K, McDonald TO, Chait A, Allen MD, Alpers CE (1996) Neovascular expression of E-selectin, intercellular adhesion molecule-1, and vascular cell adhesion molecule-1 in human atherosclerosis and their relation to intimal leukocyte content. Circulation 93:672-682
8. Hwang SJ, Ballantyne CM, Sharrett AR, Smith LC, Davis CE, Gotto AMJr, Boerwinkle E (1997) Circulating adhesion molecules VCAM-1, ICAM-1, and E-selectin in carotid atherosclerosis and incident coronary heart disease cases: the Atherosclerosis Risk In Communities (ARIC) study. Circulation 96:4219-4225
9. Blann AD, Lip GYH, Beevers DG, McCollum CN (1997) Soluble P-selectin in atherosclerosis: a comparison with endothelial cell and platelet markers. Thromb Haemost 77:1077-1080
10. Frijns CJ, Kappelle LJ, Van Gijn J, Nieuwenhuis HK, Sixma JJ, Fijnheer R (1997) Soluble adhesion molecules reflect endothelial cell activation in ischemic stroke and in carotid atherosclerosis. Stroke 28:2214-2218
11. Zeitler H, Ko Y, Zimmermann C, Nickenig G, Glänzer K, Walger P, Sachinidis A, Vetter H (1997) Elevated serum concentrations of soluble adhesion molecules in coronary artery disease and acute myocardial infarction. Eur J Med Res 2:389-394
12. Peter K, Nawroth P. Conradt C, Nordt T, Weiss T, Boehme M, Wunsch A, Allenberg J, Kubler W, Bode C (1997) Circulating vascular cell adhesion molecule-1 correlates with the extent of human atherosclerosis in contrast to circulating intercellular adhesion molecule-1, E-selectin, P-selectin, and thrombomodulin. Arterioscler Thromb Vasc Biol 17:505-512
13. Malik IS, Haskard DO (1999) Soluble adhesion molecules in ischaemic heart disease. Eur Heart J 20:990-991
14. DeGraba TJ (1997) Expression of inflammatory mediators and adhesion molecules in human atherosclerotic plaque. Neurology 49[Suppl 4]:S15-S19
15. Ciuffetti G, Lombardini R, Pasqualini L, Vaudo G (1996) Leucocyte-endothelial interactions in chronic critical limb ischaemia. Ann Intern Med Int 11:170-174
16. Galante A, Pietroiusti A, Magrini A, Carta S, Franceschelli L, Piccolo P, Pistolese GR, Martelli E, Mastino A, Matteucci C, Grelli S, Favalli C (1997) Leucocyte rheological properties are altered in patients with diffuse atherosclerosis. Thromb Haemost 77:1073-1076
17. Steiner M, Reinhardt KM, Krammer B, Ernst B, Blann AD (1994) Increased levels of soluble adhesion molecules in type 2 (non-insulin dependent) diabetes mellitus are independent of glycaemic control. Thromb Haemost 72:979-984
18. Cominacini L, Fratta Pasini A, Garbin U, Davoli A, De Santis A, Campagnola M, Rigoni A, Zenti MG, Moghetti P, Lo Cascio V (1995) Elevated levels of soluble E-selectin in patients with IDDM and NIDDM: relation to metabolic control. Diabetologia 38:1122-1124
19. Fasching P, Waldhäusl W, Wagner OF (1996) Elevated circulating adhesion molecules in NIDDM - potential mediators in diabetic macroangiopathy. Diabetologia 39:1242-1244
20. Albertini JP, Valensi P, Lormeau B, Aurousseau MH, Ferriare F, Attali JR, Gattegno L (1998) Elevated concentrations of soluble E-selectin and vascular cell adhesion molecule-1 in NIDDM. Diabetes Care 21:1008-1013
21. Bluher M, Unger R, Rassoul F, Richter V, Paschke R (2002) Relation between glycaemic control, hyperinsulinaemia and plasma concentrations of soluble adhesion molecules in patients with impaired glucose tolerance or type II diabetes. Diabetologia 45:210-216
22. Matsumoto K, Yasunori S, Nakamura H, Ueki Y, Miyake S (2002) Serum concentrations of soluble adhesion molecules are related to degree of hyperglycemia and insulin resistance in patients with type 2 diabetes mellitus. Diabetes Res Clin Pract 55:131-138
23. Ceriello A, Falleti E, Bortolotti N, Motz E, Cavarape A, Russo A, Gonano F, Bartoli E (1996) Increased circulating intercellular adhesion molecule-1 levels in type II diabetic patients: the possible role of metabolic control and oxidative stress. Metabolism 45:498-501
24. Kado S, Nagata N (1999) Circulating intercellular adhesion molecule-1, vascular cell adhesion molecule-1, and E-selectin in patients with type 2 diabetes mellitus. Diabetes Res Clin Pract 46:143-148
25. Devaraj S, Jialal I (2000) Low-density lipoprotein postsecretory modification, monocyte function, and circulating adhesion molecules in type 2 diabetic patients with and without macrovascular complications. The effect of α-tocopherol supplementation. Circulation 102:191-196
26. Albertini JP, Valensi P, Lormeau B, Vaysse, Attali JR, Gattegno L (1999) Soluble L-selectin level is a marker for coronary artery disease in type 2 diabetic patients. Diabetes Care 22:2044-2048
27. Cominacini L, Fratta Pasini A, Garbin U, Campagnola M, Davoli A, Rigoni A, Zenti MG, Pastorino AM, Lo Cascio V (1997) E-selectin plasma concentration is influenced by glycaemic control in NIDDM patients: possible role of oxidative stress. Diabetologia 40:584-589
28. Rao KMK, Hatchell DL, Cohen HJ, De La Paz M (1997) Alterations in stimulus-induced integrin expression in peripheral blood neutrophils of patients with diabetic retinopathy. Am J Med Sci 313:131-137
29. Delamaire M, Maugendre D, Moreno M, Le Goff MC, Allannic H, Genetet B (1997) Impaired leucocyte functions in diabetic patients. Diabetic Med 14:29-34
30. Senior PA, Marshall SM, Thomas TH (1999) Dysregulation of PMN antigen expression in type 2 diabetes may reflect a generalized defect of exocytosis: influence of hypertension and microalbuminuria. J Leuk Biol 65:800-807
31. Fardon NJ, Wilkinson R, Thomas TH (2002) Abnormalities in primary granule exocytosis in neutrophils from type I diabetic patients with nephropathy. Clin Sci 102:69-75
32. Alberti KGMM, Zimmet PZ (1998) Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: Diagnosis and classification of diabetes mellitus. Provisional report of a WHO consultation. Diabet Med 15:539-553
33. Mikita J, Nash G, Dormandy J (1986) A simple method of preparing white blood cells for filterability testing. Clin Hemorheol 6:635-639
34. Lennie SE, Lowe GDO, Barbenel JC, Forbes CD, Foulds WS (1987) Filterability of white blood cell subpopulations, separated by an improved method. Clin Hemorheol 7:811-816
35. Yasui K, Masuda M, Matsuoka T, Yamazaki M, Komiyama A, Akabane T, Hasui M, Kobayashi Y, Murata K (1988) Abnormal membrane fluidity as a cause of impaired dynamics of chemoattractant receptors on neonatal polymorphonuclear leukocytes: lack of modulation of the receptors by a membrane fluidizer. Pediatr Res 24:442-446
36. Masuda M, Komiyama Y, Murakami T, Murata K, Hasui M, Hirabayashi Y, Kobayashi Y (1990) Difference in changes of membrane fluidity of polymorphonuclear leukocytes stimulated with phorbol myristate acetate and formyl-methionyl-leucyl-phenylalanine: role of excited oxygen species. J Leuk Biol 47:105-110
37. Pozzan T, Lew DP, Wollheim CB, Tsien RY (1983) Is cytosolic ionized calcium regulating neutrophil activation? Science 221:1413-1415
38. Marks PW, Maxfield FR (1990) Local and global changes in cytosolic free calcium in neutrophils during chemotaxis and phagocytosis. Cell Calcium 11:181-190
39. Roe MW, Lemasters JJ, Herman B (1990) Assessment of Fura 2 for measurements of cytosolic free calcium. Cell Calcium 11:63-73
40. Soriano SG, Coxon A, Wang YF, Frosch MP, Lipton SA, Hickey PR, Mayadas TN (1999) Mice deficient in Mac-1 (CD11b/CD18) are less susceptible to cerebral ischaemia/reperfusion injury. Stroke 30:134-139
41. Chen H, Chopp M, Zhang RL, Bodzin G, Chen Q, Rusche JR, Todd RF III (1994) Anti CD-11b monoclonal antibody reduces ischaemic cell damage after transient focal cerebral ischaemia in rat. Ann Neurol 35:458-463
42. Chopp M, Zhang RL, Chen H, Li Y, Jiang N, Rusche JR (1994) Postischaemic administration of an anti-Mac-1 antibody reduces ischaemic cell damage after transient middle cerebral artery occlusion in rats. Stroke 25:869-876
43. Yenari MA, Kunis D, Sun GH, Onley D, Watson L, Turner S, Whitaker S, Steinberg GK (1998) Hu23F2G, an antibody recognizing the leukocyte CD11/CD18 integrin reduces injury in a rabbit model of transient focal cerebral ischaemia. Exp Neurol 153:223-233
44. Caimi G, Montana M, Citarrella R, Porretto F, Catania A, Lo Presti R (2002) Polymorphonuclear leukocyte integrin profile in diabetes mellitus. Clin Hemorheol Microcirc 27(2):83-89
45. 2+ content after activation in essential hypertension. Hypertension 36:813-817
46. Caimi G, Canino B, Ferrara F, Montana M, Musso M, Carollo C, Catania A, Lo Presti R (2001) Granulocyte integrins before and after activation in acute ischaemic stroke. J Neurol Sci 186:23-26
47. Buyon JP, Philips MR, Merrill JT, Slade SG, Leszczynska-Piziak J, Abramson SB (1997) Differential phosphorylation of the β2 integrin CD11b/CD18 in the plasma and specific granule membranes of neutrophils. J Leuk Biol 61:313-321
48. Carlos TM, Harlan JM (1994) Leukocyte-endothelial adhesion molecules. Blood 84:2068-2101
49. Cornejo CJ, Winn RK, Harlan JM (1997) Anti-adhesion therapy. Adv Pharmacol 39:99-142
50. Deitch JS, Williams JK, Adams MR, Fly CA, Herrington DM, Jordan RE, Nakada MT, Jakubowski JA, Geary RL (1998) Effects of beta3-integrin blockade (c7E3) on the response to angioplasty and intra-arterial stenting in atherosclerotic nonhuman primates. Arterioscler Thromb Vasc Biol 18:1730-1737
51. Barouch FC, Miyamoto K, Allport JR, Fujita K, Bursell SE, Aiello LP, Luscinskas FW, Adamis AP (2000) Integrin-mediated neutrophil adhesion and retinal leukostasis in diabetes. Invest Ophthalmol Vis Sci 41:1153-1158